Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
CYTK
CYTK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest CYTK ETF News Today | Earnings, Events & Price Alerts
CYTK News
MongoDB and Warner Bros Options Trading Activity
Feb 25 2026
NASDAQ.COM
Cytokinetics Q4 2025 Earnings Call Highlights
Feb 25 2026
seekingalpha
Cytokinetics (CYTK) Q4 2025 Earnings Transcript
Feb 25 2026
NASDAQ.COM
Cytokinetics Q4 Earnings Report Analysis
Feb 24 2026
seekingalpha
Cytokinetics' MYQORZO Approved and U.S. Launch Underway
Feb 24 2026
Yahoo Finance
Cytokinetics to Announce Q4 Earnings on February 24
Feb 23 2026
seekingalpha
Cytokinetics Secures EU Approval for MYQORZO Launch
Feb 17 2026
Newsfilter
Cytokinetics Awards Grants to Patient Advocacy Organizations
Feb 09 2026
Newsfilter
Cytokinetics Board Faces Claims of Breach of Fiduciary Duty as Stock Plummets
Jan 22 2026
Businesswire
Stocks to Consider Buying in 2026: Insights from Our Roundtable Experts, Including DoorDash and LVMH
Jan 16 2026
Barron's
Cytokinetics (CYTK) and FuboTV (FUBO) Options Volume Surge
Jan 12 2026
NASDAQ.COM
Cytokinetics Faces Shareholder Investigation Over Alleged Misleading Statements
Jan 02 2026
Globenewswire
Biotech Stocks Surge at Year-End 2025, ETFs Gain 35.84%
Dec 31 2025
Benzinga
Cytokinetics Faces Shareholder Investigation Over Alleged Misstatements
Dec 30 2025
Globenewswire
Edgewise Therapeutics Updates EDG-7500 Phase 2 Trial Progress, Shares Rise 17.96%
Dec 24 2025
Benzinga
CYTK Receives FDA Approval for Myqorzo, Launch Expected in 2026
Dec 22 2025
Newsfilter
Show More News
